Propylene Oxide

Propylene Oxide

SCHEMBL11889807

CC1CO1.O=S(=O)(O)c1ccc2ccnc(Cl)c2c1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARG Q86W56 1/20 0.53
PLG P00747 2/20 0.38
PLAU P00749 2/20 0.38
PLAT P00750 2/20 0.38
ALDH1A1 P00352 4/20 0.38
CASP6 P55212 2/20 0.38
HSD17B10 Q99714 2/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
HTR6 P50406 2/20 0.36
TDP1 Q9NUW8 3/20 0.35
MAPT P10636 3/20 0.35
LMNA P02545 2/20 0.35
KDM4E B2RXH2 2/20 0.35
HTT P42858 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KMT2A Q03164 3/20 0.34
APEX1 P27695 2/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7536983 0.76 HSD17B10 (0.46) PARGPLGPLAUPLATALDH1A1
SCHEMBL17824799 0.74 PARG (0.58) PARGPLGPLAUPLATALDH1A1
SCHEMBL6993419 0.73 PLAU (0.60) PARGPLGPLAUPLATMAPT
SCHEMBL27527771 0.70 PARG (0.53) PARGPLGPLAUPLATALDH1A1
SCHEMBL17825169 0.69 PARG (1.00) PARG
SCHEMBL14514049 0.68 ALDH1A1 (0.62) ALDH1A1CASP6HSD17B10CYP2C9CYP2C19
SCHEMBL29786977 0.67 LMNA (0.50) PARGALDH1A1MAPTLMNAKMT2A
SCHEMBL1317870 0.67 LMNA (0.50) PARGALDH1A1MAPTLMNAKMT2A
SCHEMBL6998566 0.66 PLG (0.65) PARGPLGPLAUPLATALDH1A1
SCHEMBL18691153 0.65 LMNA (0.44) PARGMAPTLMNAAPEX1HIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2332917-B1 Compounds for PIM kinase inhibition and for treating malignancy SYGNIS BIOSCIENCE GMBH & CO KG (DE) 2012-08-01 EP disclosed